Skip to main content

This job has expired

You will need to login before you can apply for a job.

Executive Director, TA Lead, Oncology, USMA

Employer
Daiichi Sankyo
Location
Basking Ridge, NJ, United States
Start date
Feb 16, 2021

View more

Discipline
Science/R&D, Oncology
Required Education
Doctorate/PHD/MD
Position Type
Full time
Hotbed
Pharm Country

Job Details

Join a Legacy of Innovation 110 Years and Counting!

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.

Job Summary:

This position oversees and manages US Medical Affairs activities including strategy, communications, and medical affairs directed clinical activities across the oncology portfolio. The position has leadership responsibility for Medical Affairs personnel working on Oncology products that can range from late clinical phases through launch and post-approval in multiple therapeutic areas. In partnership with the Global Medical Affairs and Oncology Business Unit Brand Teams, the Medical Affairs lead develops the medical/commercial strategy based on the scientific development and appropriate communication for the products. The position must effectively collaborate with Clinical Development and with Alliance partners to effectively guide the scientific efforts needed in support of Daiichi Sankyo brands. Additionally, the Executive Director contributes to excellence in clinical research by developing strategies for lifecycle management, IIS programs and post approval clinical programs in consultation with Oncology Business Unit, Clinical Development and outside experts, and by building the image of the company as a partner in research projects

Responsibilities:

This position oversees and manages US Medical Affairs activities including strategy, communications, and medical affairs directed clinical activities across the oncology portfolio. The position has leadership responsibility for Medical Affairs personnel working on Oncology products that can range from late clinical phases through launch and post-approval in multiple therapeutic areas. In partnership with the Global Medical Affairs and Oncology Business Unit Brand Teams, the Medical Affairs lead develops the medical/commercial strategy based on scientific development and appropriate communication for the products. The position must effectively collaborate with Clinical Development and with Alliance partners to effectively guide the scientific efforts needed in support of Daiichi Sankyo brands. Additionally, the Executive Director contributes to excellence in clinical research by developing strategies for lifecycle management, IIS programs and post approval clinical programs in consultation with Oncology Business Unit, Clinical Development and outside experts, and by building the image of the company as a partner in research projects

Serve as the face of Daiichi Sankyo US Medical Affairs to external stakeholders. Oversee a Medical Affairs oncology team that works alongside Oncology Field Medical Affairs for interactions with Key External Experts in Oncology including advisory boards, congress activities, investigator initiated studies, advocacy, and sponsorships. Interact with investigators and members of the medical community to assist in understanding current academic, clinical trial and practice issues related to DS Oncology development and therapeutic strategies.

Partner across the Oncology Business Unit to oversee and assume responsibility for brand plans, including Medical objectives, strategies and tactics leading up to launch and carrying through to later stages of commercialization. Foster cross-asset, therapeutic area strategies including scientific exchange for biomarkers and companion diagnostics.

For Oncology portfolio serve as the US Medical Affairs lead in development committees and global medical affairs activities. Represent Medical Affairs in new product planning, life cycle management, co-development and co-promotion discussions. Foster bidirectional communication and alignment between US and Global Medical Affairs.

Oversee the interpretation, publication/ public disclosure and interpretation of scientific data generated by studies conducted by the Oncology teams. Oversee the development of scientific content for medical communication and scientific education initiatives that occur as a result of studies conducted by the Oncology teams as well as strategies related to competitive intelligence.

Attract and develop US Medical Affairs talent in oncology. Oversee the team, as well as, develop and effectively manage annual operating plan and budget for the Oncology Medical Strategy Group. Support the US Medical Affairs department through participation on the Medical Affairs Leadership Team and serve as the voice for oncology within the department.

Qualifications: Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.

Education/Experience:

MD degree preferred, PhD as a minimum requirement; Board Certified/Eligible in Oncology or related specialty preferred, or equivalent clinical or research experience

Minimum of 10 years of experience in clinical / research / academic medicine or equivalent pharmaceutical industry experience. Proven track record of working successfully with cross-functional internal teams as well as external stakeholders to achieve goals. Experience with oncology medical strategies and clinical trial implementation is required. The Executive Director will serve as a resource across the Oncology Business Unit and would be expected to have significant knowledge of oncology basic science, mechanisms of action, treatment landscapes and clinical practice patterns across a broad range of therapeutic areas.

Excellent written and oral communication skills, particularly strong formal presentation skills; strong interpersonal skills commensurate with the need to work closely with both outside physicians/ scientists and numerous in-house support groups; strong managerial skills to lead effectively and motivate staff; demonstrated high proficiency in problem solving ability and possession of strong scientific analytical skills; excellent planning and organizational skills; experience in setting and adhering to departmental budgets; knowledge of scientific methods, research design and medical practices and procedures that would be acquired through clinical experience and clinical research studies.

Basic knowledge of clinical trial design and biostatistics; proficiency using standard software suites

Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.
Job Title
Executive Director, TA Lead, Oncology, USMA

City
Basking Ridge

Functional Area
DSUSB Medical Affairs

State
New Jersey

Company

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology.

With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.

For more information, please visit: www.daiichisankyo.com.

Daiichi Sankyo, Inc., headquartered in Basking Ridge, New Jersey, is a member of the Daiichi Sankyo Group. To learn more about Daiichi Sankyo, Inc., please visit www.dsi.com.

STOCK EXCHANGE: Tokyo Stock Exchange

STOCK SYMBOL: 4568

Twitter

Company info
Website
Phone
(908) 992-6400
Location
211 Mt. Airy Road
Basking Ridge
New Jersey
07920
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert